基于C反应蛋白新炎症因子组合在结直肠癌诊断中的临床价值
Clinical Value of Novel Inflammatory Factor Combinations Based on C-Reactive Protein in the Diagnosis of Colorectal Cancer
DOI: 10.12677/acm.2025.1592501, PDF,    科研立项经费支持
作者: 苏友玉, 徐大方*, 郑思洋, 胡 洁:湖州师范学院附属第一医院普通外科,浙江 湖州;石 茜:湖州师范学院附属第一医院中心实验室,浙江 湖州;强 锋:湖州师范学院附属第一医院消化内科,浙江 湖州
关键词: 淋巴细胞/C反应蛋白比值(LCR)C反应蛋白/白蛋白比值(CAR)CA199CEA结直肠癌Lymphocyte/C-Reactive Protein Ratio (LCR) C-Reactive Protein/Albumin Ratio (CAR) CA199 CEA Colorectal Cancer
摘要: 目的:探讨基于C反应蛋白为基础的新炎症因子组合LCR、CAR及CA199、CEA等指标在结直肠癌临床诊断中的价值。方法:将2020年04月至2023年04月在本院手术治疗的结直肠癌患者163例设置为结直肠癌组,93例结直肠息肉组为对照组。通过比较淋巴细胞/C反应蛋白比值(LCR)、C反应蛋白/白蛋白比值(CAR),CA199及CEA在两组中的差异,与临床病理特征关联分析,ROC曲线绘制检测结果。结果:结直肠癌组中CAR、CEA、CA199表达明显增高,LCR表达下降,各组存在统计学差异(P < 0.001)。LCR在肿瘤浸润深度(T3 + T4)组表达明显低于(T1 + T2)组,有淋巴结转移组表达降低,TNM分期为(III + IV)表达明显低于(I + II)组,各组之间均有统计学差异。而CAR、CEA、CA199表达与LCR相反,各组统计学差异明显(P < 0.05)。ROC提示联合诊断敏感度为56.4%,特异性为90.3%。结论:LCR、CAR、CA199、CEA水平与结直肠癌患者的临床病理特征相关,对结直肠癌的诊断有潜在价值,联合检测能提高对结直肠癌诊断的特异度。
Abstract: Objective: Exploring the value of new inflammatory factor combinations based on C-reactive protein, such as LCR, CAR, CA199, CEA in the clinical diagnosis of colorectal cancer. Methods: A total of 163 patients with colorectal cancer who received surgical treatment in our hospital from April 2020 to April 2023 were selected as the colorectal cancer group and 93patients with colorectal polyp group as the control group. By comparing the differences of lymphocyte/C-reactive protein ratio (LCR), C-reactive protein/albumin ratio (CAR), CA199 and CEA in the two groups, correlation analysis was performed with clinicopathological features, and the detection efficiency results were plotted by ROC curve. Results: The expressions of CAR, CEA and CA199 were significantly increased in colorectal cancer group, while the expressions of LCR were decreased, with statistical differences among all groups (P < 0.001). The expression of LCR in the depth of tumor invasion (T3 + T4) group was significantly lower than that in the (T1 + T2) group, the expression of LCR was decreased in the group with lymph node metastasis, and the expression of TNM staging (III + IV) was significantly lower than that in the (I + II) group, with statistical differences among all groups. The expressions of CAR, CEA and CA199 were opposite to those of LCR, and there were statistical differences among all groups (P < 0.05). The ROC curve indicated that the sensitivity and specificity of combined diagnosis were 55.2% and 90.3%. Conclusions: The levels of LCR, CAR, CA199 and CEA are correlated with the clinicopathologic characteristics of patients with colorectal cancer, and have potential value in the diagnosis of colorectal cancer. Combined detection can improve the sensitivity of the diagnosis of colorectal cancer.
文章引用:苏友玉, 徐大方, 石茜, 强锋, 郑思洋, 胡洁. 基于C反应蛋白新炎症因子组合在结直肠癌诊断中的临床价值[J]. 临床医学进展, 2025, 15(9): 375-384. https://doi.org/10.12677/acm.2025.1592501

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Machado Carvalho, J.V., Dutoit, V., Corrò, C. and Koessler, T. (2023) Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Cells, 12, Article No. 413. [Google Scholar] [CrossRef] [PubMed]
[3] Song, X.D., Wang, Y.N., Zhang, A.L. and Liu, B. (2019) Advances in Research on the Interaction between Inflammation and Cancer. Journal of International Medical Research, 48, 1473-2300. [Google Scholar] [CrossRef] [PubMed]
[4] Okugawa, Y., Toiyama, Y., Yamamoto, A., Shigemori, T., Ide, S., Kitajima, T., et al. (2019) Lymphocyte-c-Reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer. Annals of Surgery, 272, 342-351. [Google Scholar] [CrossRef] [PubMed]
[5] Miyatani, K., Sawata, S., Makinoya, M., Miyauchi, W., Shimizu, S., Shishido, Y., et al. (2022) Combined Analysis of Preoperative and Postoperative Lymphocyte-C-Reactive Protein Ratio Precisely Predicts Outcomes of Patients with Gastric Cancer. BMC Cancer, 22, Article No. 641. [Google Scholar] [CrossRef] [PubMed]
[6] Yamamoto, M., Saito, H., Uejima, C., Tanio, A., Takaya, S., Sakamoto, T., et al. (2018) Prognostic Value of the Combination of Pre-and Postoperative C-Reactive Protein in Colorectal Cancer Patients. Surgery Today, 48, 986-993. [Google Scholar] [CrossRef] [PubMed]
[7] Holm, M., Saraswat, M., Joenväärä, S., Ristimäki, A., Haglund, C. and Renkonen, R. (2018) Colorectal Cancer Patients with Different C-Reactive Protein Levels and 5-Year Survival Times Can Be Differentiated with Quantitative Serum Proteomics. PLOS ONE, 13, e0195354. [Google Scholar] [CrossRef] [PubMed]
[8] Aires, F., Rodrigues, D., Lamas, M.P., Herdeiro, M.T., Figueiras, A., Oliveira, M.J., et al. (2022) C-reactive Protein as Predictive Biomarker for Response to Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Retrospective Study. Cancers, 14, Article No. 491. [Google Scholar] [CrossRef] [PubMed]
[9] Yildirim, M. and Koca, B. (2021) Lymphocyte C-Reactive Protein Ratio: A New Biomarker to Predict Early Complications after Gastrointestinal Oncologic Surgery. Cancer Biomarkers, 31, 409-417. [Google Scholar] [CrossRef] [PubMed]
[10] Ou, W., Zhou, C., Zhu, X., Lin, L. and Xu, Q. (2021) Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer. OncoTargets and Therapy, 14, 337-346. [Google Scholar] [CrossRef] [PubMed]
[11] 曾凡鹏, 路庆艳, 李青. 术前HRP、LCR和CEA水平在结直肠癌中的临床价值分析[J]. 国际检验医学杂志, 2022, 43(7): 818-822.
[12] Tsuzuki, S., Kimura, S., Fukuokaya, W., Yanagisawa, T., Hata, K., Miki, J., et al. (2020) Modified Glasgow Prognostic Score Is a Pre-Surgical Prognostic Marker of Disease Mortality in Upper Urinary Tract Urothelial Carcinoma. Japanese Journal of Clinical Oncology, 51, 138-144. [Google Scholar] [CrossRef] [PubMed]
[13] Záhorec, R., Marek, V., Waczulíková, I., Veselovský, T., Palaj, J., Kečkéš, Š., et al. (2021) Predictive Model Using Hemoglobin, Albumin, Fibrinogen, and Neutrophil-to-Lymphocyte Ratio to Distinguish Patients with Colorectal Cancer from Those with Benign Adenoma. Neoplasma, 68, 1292-1300. [Google Scholar] [CrossRef] [PubMed]
[14] Konishi, S., Hatakeyama, S., Tanaka, T., Ikehata, Y., Tanaka, T., Hamano, I., et al. (2019) Prognostic Significance of Preoperative C‐Reactive Protein/Albumin Ratio Is a Predictive Factor for Prognosis in Patients with Metastatic Renal Cell Carcinoma. International Journal of Urology, 26, 992-998. [Google Scholar] [CrossRef] [PubMed]
[15] Liu, Z., Chen, L., Sun, F., Lv, B., Ge, X., Shao, L., et al. (2022) C-Reactive Protein/Albumin Ratio on the First Day after Surgery Predicts Short-Term Complications of Gastrectomy for Gastric Cancer. Nutrition and Cancer, 74, 3574-3581. [Google Scholar] [CrossRef] [PubMed]
[16] Murakawa, M., Yamamoto, N., Kamioka, Y., Kamiya, M., Kobayashi, S., Ueno, M., et al. (2019) Clinical Implication of Pre-Operative C-Reactive Protein-Albumin Ratio as a Prognostic Factor of Patients with Pancreatic Ductal Adenocarcinoma: A Single-Institutional Retrospective Study. In Vivo, 34, 347-353. [Google Scholar] [CrossRef] [PubMed]
[17] Ikeguchi, M. and Ashida, K. (2017) Prognostic Significance of C-Reactive Protein/Albumin Ratio in Patients with Locally Advanced Unresectable Colorectal Cancer. Indian Journal of Surgical Oncology, 8, 263-266. [Google Scholar] [CrossRef] [PubMed]
[18] Zhou, Y., Cheng, F., Zhang, Z., Xiang, J., Xue, T., Ye, Q., et al. (2022) Preoperative Absolute Lymphocyte Count to Carcinoembryonic Antigen Ratio Is a Superior Predictor of Survival in Stage I to III Colorectal Cancer. Clinical Medicine Insights: Oncology, 16, 1-10. [Google Scholar] [CrossRef] [PubMed]
[19] Gunawardene, A., Larsen, P., Shekouh, A. and Dennett, E. (2018) Pre‐Operative Carcinoembryonic Antigen Predicts Survival Following Colorectal Cancer Surgery with Curative Intent. ANZ Journal of Surgery, 88, 1311-1315. [Google Scholar] [CrossRef] [PubMed]
[20] Kim, H., Kim, H.S., Yang, S.Y., Han, Y.D., Cho, M.S., Hur, H., et al. (2021) Early Recurrence after Neoadjuvant Chemoradiation Therapy for Locally Advanced Rectal Cancer: Characteristics and Risk Factors. Asian Journal of Surgery, 44, 298-302. [Google Scholar] [CrossRef] [PubMed]
[21] Jiang, Y., Zou, Z., Zhang, Z., Zhang, Y., Sun, Y. and Liang, B. (2020) Long-Term Outcomes of Radical Surgery for Transverse Colon Cancer Staged from I to IIIC. Cancer Management and Research, 12, 13043-13049. [Google Scholar] [CrossRef] [PubMed]
[22] Wu, J., Wu, M. and Wu, Q. (2020) Identification of Potential Metabolite Markers for Colon Cancer and Rectal Cancer Using Serum Metabolomics. Journal of Clinical Laboratory Analysis, 34, 1-7. [Google Scholar] [CrossRef] [PubMed]